Petitions  Mr. Speaker, I am pleased to present this petition regarding CCSVI. Thirty thousand treatments have been undertaken in 60 countries, while Canada has failed to begin clinical trials. The U.S. is already undertaking three FDA approved clinical trials. The U.K. encourages robust

Petitions  Mr. Speaker, I am pleased to present this petition regarding CCSVI. The petitioners want to know why the government continues to ignore the evidence from over 30,000 CCSVI procedures, scientific studies from nine CCSVI conferences and returning Canadian MS patients. They want

Pan-Canadian Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI) Act  moved for leave to introduce Bill C-410, An Act to establish a Pan-Canadian Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI). Mr. Speaker, my bill aims to establish a pan-Canadian strategy for chronic cerebrospinal venous insufficiency, or CCSVI. The bill calls

Bill C-410 An Act to establish a Pan-Canadian Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI)

C-410 First Session, Forty-first Parliament, 60-61 Elizabeth II, 2011-2012 HOUSE OF COMMONS OF CANADA BILL C-410 An Act to establish a Pan-Canadian Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI) first reading, March 26, 2012 Ms. Duncan (Etobicoke North) 411578

Health committee   to test the safety and efficacy of the CCSVI procedure. CIHR is currently selecting the research team who will conduct this clinical trial. The funding for the study will start as soon as May of this year. We're also establishing a monitoring system to capture better information on MS

Health committee   committee to provide advice on emerging issues related to traditional Chinese medicine. Also making headlines in recent months has been the debate on MS and CCSVI. I want members of this committee to know that the government shares the desire of MS patients to find a cure

Petitions   call upon the Minister of Health to consult experts who have practical experience in dealing with CCSVI. They urge the minister to proceed with phase III clinical trials on an urgent basis. They also urge the minister to require follow-up of patients with Doppler ultrasound

Petitions  Mr. Speaker, I am pleased to present this petition regarding CCSVI. Former deputy surgeon general and director general of the Laboratory Centre for Disease Control, Dr. Michael Shannon, writes: Having lived through the restructuring of the Canadian Blood System in the late 90

Health committee  Thank you very much, Madam Chair. I too want to welcome you here. It's always a pleasure to have you appear before the committee. I think your briefings to us are always full of excellent information. I want to go back to a comment my colleague made about the anti-CCSVI

Health committee   of the Canadian public and the Canadian government. That's the first thing. The second thing concerns more specifically CCSVI, which is that we must abide by the principle of clinical research, and get the information, as we're actually proceeding to get it, in a phased fashion.

Health committee  Thank you. I also want to go back to the MS monitoring system, which Ms. Elmslie spoke about, that was announced in March 2011. I know my colleague asked whether or not we will be tracking all Canadians who have received the CCSVI treatment. I want to know if you can expand

Health committee  Thank you very much. I'll start by saying that, as you know, the monitoring system is for all MS patients, including those who have chosen to have the CCSVI procedure, but not exclusive to those patients. The reason it's important to have this monitoring system is that right

Health committee  Thank you. Dr. Beaudet, this is a hard question. You know I'm not a combative person; this is difficult. In light of there being an absolutely robust anti-CCSVI campaign, how is CIHR going to guarantee a non-biased study? That's of real concern to the patients.

Health committee   published reports on CCSVI intervention, much of the support for endovascular interventions in CCSVI currently comes from anecdotal patient self-reports posted on web sites, blogs, and chat rooms. Prospective randomized control trials will be necessary to fully understand the impact

Health committee   to protect the Canadian public was at least in part driven by financial considerations and tragically cost thousands of Canadian lives and ultimately the Canadian taxpayer billions in health care costs and law suits. Is CCSVI any different? Having lived through the restructuring